Nachrichten iShares Nasdaq US Biotechnology UCITS ETF - USD

ETF

A2DWAW

IE00BYXG2H39

BTEK

Verzögert London S.E. 17:35:06 28.03.2024 % 5 Tage % 1. Jan.
6,428 USD +0,08 % Intraday Chart für iShares Nasdaq US Biotechnology UCITS ETF - USD +2,43 % +0,74 %
Mehr Börsen-Nachrichten
IShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF Declares Interim Dividend, Payable on 29 December 2023
IShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF Declares Interim Dividend, Payable on 30 December 2022
IShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF Declares Interim Dividend, Payable on 29 June 2022
IShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF Announces Interim Distribution for the Year 2021, Payable on December 31, 2021
Ishares Iv Public Limited Company - Ishares NASDAQ US Biotechnology UCITS ETF Announces Interim Dividend for the year 2021, Payable on 30 June 2021
IShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF Announces Interim Distribution for the Financial Year 2020, Payable on 23 December 2020
IShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF Announces Interim Distribution for the Financial Year 2020, Payable on 24 June 2020
Ishares Iv Public Limited Company -iShares NASDAQ US Biotechnology UCITS ETF Announces Interim Distribution for the Financial Year 2019, Payable on 27 December 2019
IShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF Announces Interim Distribution for the Financial Year 2019, Payable on 26 June 2019
IShares IV Public Limited Company - iShares Edge MSCI World Value Factor UCITS ETF Announces Interim Distribution, Payable on 28 December 2018
Weiterlesen

Beschreibung

ISIN Code IE00BYXG2H39
Verwaltungsgebühren 0.35%
Anlageklassen
Branche
Wert
Währung
Fondsgesellschaft
Basiswert NASDAQ Biotechnology Net Total Return Index - USD

Merkmale

Gerichtsstand
Replikationsmethode
Replikationsmodell
Erstellungsdatum
19.10.2017
Dividenden-Politik
Geographischer Fokus

Distribution

Investor Privatperson
Qualifizierter Investor

Entwicklungen der ausstehenden Beträge ( 29.02.2024 )

Volumen (EUR) 412 M€
Volumen 1M 413 M€
Volumen 3M 359 M€
Volumen 6M 419 M€
Volumen 12M 440 M€
  1. Börse
  2. ETF
  3. ETF iShares Nasdaq US Biotechnology UCITS ETF - USD - London S.E.
  4. Nachrichten iShares Nasdaq US Biotechnology UCITS ETF - USD